Chronic heart failure: an overview of conventional treatment versus novel approaches
- 1 December 2005
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 2 (12) , 628-638
- https://doi.org/10.1038/ncpcardio0371
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failureExpert Opinion on Investigational Drugs, 2004
- Erythropoietin regulates endothelial progenitor cellsBlood, 2004
- Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular ContainmentCirculation Research, 2003
- β-Blockers in Chronic Heart FailureCirculation, 2003
- Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in PhospholambanScience, 2003
- Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trialAmerican Heart Journal, 2003
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999